Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Drug discovery

Research Field Informatics

AI Picks Parkinson’s

| James Strachan

Could artificial intelligence help repurpose old drugs for suffers of the degenerative disorder?

Disease Area Drug discovery

Go Forth and Find a Flu Vaccine

Bill Gates has issued a challenge to help researchers push for a universal flu vaccine.

Tools & Techniques Drug discovery

Old Drugs, New Computational Tools

| Misagh Naderi

Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.

Research Field Drug discovery

Recognizing Friend from Foe

| Werner Cautreels

New solutions are needed to teach the immune system to recognize biological drugs as partners rather than plunderers.

Research Field Cancer

Staying On Target

| Roisin McGuigan

What characteristics make a cancer therapy more likely to effectively treat disease?

Research Field Clinical trials

Celebrating the Digital Age

| Sophie Kornowski-Bonnet

Digital technologies could transform healthcare.

Tools & Techniques Drug discovery

Medicina Ex Machina

| Roisin McGuigan

Artificial intelligence could have a huge impact on drug discovery.

Disease Area Drug discovery

Algal Boom

| Andrew Dahl

Algae are bacteria-fight experts. Why aren’t we using them more for drug discovery?

Outside the Lab Analytical science

Faster for Pharma

Sitting Down With... Melissa Hanna-Brown, Analytical Technology & Innovation Lead, Pfizer Global R&D, Sandwich, UK.

Outside the Lab Drug discovery

A Problem Shared…

| Roisin McGuigan

It’s time for pharma to join the crowdsourcing revolution.

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register